A Phase IV 48 Week, Open Label, Pilot Study of Kaletra and Intelence Tablets in Naive Subjects.
Phase of Trial: Phase IV
Latest Information Update: 04 May 2017
At a glance
- Drugs Etravirine (Primary) ; Lopinavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms KALYINTE
- 27 Apr 2017 Status changed from recruiting to completed.
- 16 Jan 2010 New trial record